FDA rebukes 17 firms for selling fake Alzheimer's drugs
The U.S. Food and Drug Administration (FDA) has warned more than a dozen companies against selling unapproved products which claim to treat Alzheimer's disease and other serious ailments, the agency said on Monday.
Study may help diagnose and identify people at risk of developing Alzheimer ’s much earlierHumans can make fresh brain cells until they are well into their 90s, but the production of new neurons falls in those with Alzheimer ’s, even when the disease has recently taken hold, scientists have found.The findings may help doctors to diagnose Alzheimer ’s at an earlier stage, and identify those most at risk who may benefit from exercise and other interventions that could boost the production of new brain cells.Continue reading...
After losing more than $18 billion of its value last week after ending two late-stage trials of their experimental Alzheimer ’s disease treatment, Biogen said it would buy back shares worth $5 billion.
An FDA advisory panel questions the evidence showing beneficial effects of a therapy that combines transcranial magnetic stimulation with cognitive training.Medscape Medical News
The study could lead to new ideas for treating Alzheimer's disease, say the researchers.
Condition: Early Alzheimer's Disease Interventions: Drug: BAN2401; Drug: Placebo Sponsor: Eisai Inc. Recruiting
Condition: Dementia With Lewy Bodies Interventions: Drug: Placebo Oral Tablet; Drug: Bosutinib Oral Tablet Sponsors: Georgetown University; Alzheimer's Association Recruiting
Conditions: Vestibular Diseases; Alzheimer Disease; Cognitive Impairment Intervention: Behavioral: Vestibular Physical Therapy Sponsors: University of Pittsburgh; Johns Hopkins University Not yet recruiting
BARBARA WINDSOR is best known for playing the infamous Peggy Mitchell in BBC soap opera EastEnders. The actress left the show in 2016 much to the dismay of fans. But her departure came shortly after she was diagnosed with Alzheimer ’s disease.
MONDAY, March 25, 2019 -- Patients with poor cognitive function have significantly lower levels of Alzheimer disease-related biomarkers in the vitreous humor, according to a study published March 8 in the Journal of Alzheimer's Disease. Lauren M....
Despite doubts last year about human adult neurogenesis, a study shows even 80-year-olds develop new cells in the hippocampus, but such growth is diminished in patients with Alzheimer's disease.